Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 252201 - 252220 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Greece | (L01EX10) midostaurin (adm: O) | RYDAPT SOFT.CAPS 25MG/CAP BTx112 καψάκια (4 BLIST x28) καψάκια σε BLISTERS PA/Al/PVC-Al) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute;Mastocytosis | NOVARTISEUROPHARMLIMITED,IRELAND |
| Greece | (L01EX12) larotrectinib (adm: O) | VITRAKVI ORAL.SOL 20mg/ml BTx1 φιάλη (γυάλινη)x 100 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BAYERAG,LEVERKUSEN,GERMANY |
| Greece | (L01EX12) larotrectinib (adm: O) | VITRAKVI CAPS 100mg/cap BTx1 φιάλη (HDPE)x 56 καψάκια | n/a | Retail price with vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BAYERAG,LEVERKUSEN,GERMANY |
| Greece | (L01EX12) larotrectinib (adm: O) | VITRAKVI CAPS 25mg/cap BTx1 φιάλη (HDPE)x 56 καψάκια | n/a | Retail price with vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BAYERAG,LEVERKUSEN,GERMANY |
| Greece | (L01EX13) gilteritinib (adm: O) | XOSPATA F.C.TAB 40MG/TAB BTx84 δισκία σε blisters (OPA/αλουμινίου/PVC/αλουμινίου) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute | ASTELLASPHARMAEUROPEB.V.,LEIDEN,NETHERLANDS |
| Greece | (L01EX14) entrectinib (adm: O) | ROZLYTREK CAPS 100MG/CAP Φιάλη (HDPE)x30 καψάκια | n/a | Retail price with vat |
$0-0 |
$0-0 |
Cancer;Carcinoma, Non-Small-Cell Lung | ROCHEREGISTRATIONGMBH,GERMANY |
| Greece | (L01EX14) entrectinib (adm: O) | ROZLYTREK CAPS 200MG/CAP Φιάλη (HDPE)x90 καψάκια | n/a | Retail price with vat |
$0-0 |
$0-0 |
Cancer;Carcinoma, Non-Small-Cell Lung | ROCHEREGISTRATIONGMBH,GERMANY |
| Greece | (L01EX23) pralsetinib (adm: O) | GAVRETO CAPS 100MG/CAP ΦΙΑΛΗ (HDPE) X 120 ΚΑΨΑΚΙΑ | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | BLUEPRINTMEDICINES(NETHERLANDS)B.V.,THENETHERLANDS |
| Greece | (L01FA01) rituximab | MABTHERA C/S.SOL.IN 100MG/10ML VIAL BTx2VIALSx10ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Arthritis, Rheumatoid;Leukemia, Lymphocytic, Chronic, B-Cell | ROCHEREGISTRATIONGMBH,GERMANY |
| Greece | (L01FA01) rituximab | RIXATHON C/S.SOL.IN 100MG/10ML VIAL (10MG/ML) 2 VIALS x 10ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Arthritis, Rheumatoid;Leukemia, Lymphocytic, Chronic, B-Cell;Wegener Granulomatosis;Microscopic Polyangiitis;Pemphigus | SANDOZGMBH,KUNDL,AUSTRIA |
| Greece | (L01FA01) rituximab | RUXIENCE C/S.SOL.IN 100MG/VIAL BTx1 vial | n/a | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell;Arthritis, Rheumatoid;Microscopic Polyangiitis;Pemphigus | PFIZEREUROPEMAEEIG,BELGIUM |
| Greece | (L01FA01) rituximab | MABTHERA C/S.SOL.IN 500MG/50ML VIAL BTx1VIALx50ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Arthritis, Rheumatoid;Leukemia, Lymphocytic, Chronic, B-Cell | ROCHEREGISTRATIONGMBH,GERMANY |
| Greece | (L01FA01) rituximab | RIXATHON C/S.SOL.IN 500MG/50ML VIAL (10MG/ML) 1 VIAL x 50ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Arthritis, Rheumatoid;Leukemia, Lymphocytic, Chronic, B-Cell;Wegener Granulomatosis;Microscopic Polyangiitis;Pemphigus | SANDOZGMBH,KUNDL,AUSTRIA |
| Greece | (L01FA01) rituximab | RUXIENCE C/S.SOL.IN 500MG/VIAL BTx1 vial | n/a | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell;Arthritis, Rheumatoid;Microscopic Polyangiitis;Pemphigus | PFIZEREUROPEMAEEIG,BELGIUM |
| Greece | (L01FA01) rituximab | MABTHERA INJ.SOL 1400MG/11.7ML BTxVIALx15ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Arthritis, Rheumatoid;Leukemia, Lymphocytic, Chronic, B-Cell | ROCHEREGISTRATIONGMBH,GERMANY |
| Greece | (L01FB01) inotuzumab ozogamicin | BESPONSA PD.C.S.INF 1MG/VIAL BTx1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | PFIZEREUROPEMAEEIG,BELGIUM |
| Greece | (L01FC01) daratumumab | DARZALEX C/S.SOL.IN 100mg/5ml VIAL BTx1 VIAL x5 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | JANSSEN-CILAGINTERN.NV.,BELGIUM |
| Greece | (L01FC01) daratumumab | DARZALEX C/S.SOL.IN 400mg/20ml VIAL BTx1 VIAL x20 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | JANSSEN-CILAGINTERN.NV.,BELGIUM |
| Greece | (L01FC01) daratumumab | DARZALEX INJ.SOL 1800MG/VIAL (120 MG/ML) BTx1VIAL x 15ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | JANSSEN-CILAGINTERN.NV.,BELGIUM |
| Greece | (L01FC02) isatuximab | SARCLISA C/S.SOL.IN 20MG/ML 1 VIAL x 25 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | SANOFIWINTHROPINDUSTRIE,FRANCE |
Pages
